Amicus Therapeutics (FOLD) Intangibles (2016 - 2025)
Amicus Therapeutics (FOLD) has disclosed Intangibles for 13 consecutive years, with $13.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Intangibles fell 19.09% year-over-year to $13.9 million, compared with a TTM value of $13.9 million through Dec 2025, down 19.09%, and an annual FY2025 reading of $13.9 million, down 19.09% over the prior year.
- Intangibles was $13.9 million for Q4 2025 at Amicus Therapeutics, down from $14.7 million in the prior quarter.
- Across five years, Intangibles topped out at $23.0 million in Q1 2021 and bottomed at $13.9 million in Q4 2025.
- Average Intangibles over 5 years is $20.3 million, with a median of $21.7 million recorded in 2023.
- The sharpest move saw Intangibles changed 0.0% in 2021, then fell 19.09% in 2025.
- Year by year, Intangibles stood at $23.0 million in 2021, then changed by 0.0% to $23.0 million in 2022, then decreased by 10.91% to $20.5 million in 2023, then dropped by 16.07% to $17.2 million in 2024, then dropped by 19.09% to $13.9 million in 2025.
- Business Quant data shows Intangibles for FOLD at $13.9 million in Q4 2025, $14.7 million in Q3 2025, and $15.6 million in Q2 2025.